WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004029069) HYBRIDOMAS PRODUCING HIGH LEVELS OF HUMAN SEQUENCE ANTIBODY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/029069    International Application No.:    PCT/IB2003/004089
Publication Date: 08.04.2004 International Filing Date: 18.09.2003
Chapter 2 Demand Filed:    15.10.2003    
IPC:
C07K 16/00 (2006.01), C07K 16/28 (2006.01)
Applicants: PFIZER PRODUCTS INC. [US/US]; Eastern Point Road, Groton, CT 06340 (US) (For All Designated States Except US).
LEE, Shih-jen, Edward [US/US]; (US) (For US Only).
WASILKO, David, John [US/US]; (US) (For US Only).
HERMANS, William, Roger [US/US]; (US) (For US Only)
Inventors: LEE, Shih-jen, Edward; (US).
WASILKO, David, John; (US).
HERMANS, William, Roger; (US)
Agent: LUMB, J., Trevor; Pfizer Inc., 201 Tabor Road, Morris Plains, NJ 07950 (US)
Priority Data:
60/415,088 30.09.2002 US
Title (EN) HYBRIDOMAS PRODUCING HIGH LEVELS OF HUMAN SEQUENCE ANTIBODY
(FR) HYBRIDOMES GENERANT DES TAUX ELEVES D'ANTICORPS CONTRE DES SEQUENCES HUMAINES
Abstract: front page image
(EN)Hybridoma cell line producing high levels of human sequence antibody. Also described is a hybridoma cell line producing human sequence antibodies that is adapted for growth in serum-free media or animal-derived-components-free media. A hybridoma cell line producing anti-CTLA4 antibodies is most preferred.
(FR)L'invention porte sur des lignées cellulaires d'hybridomes générant des taux élevés d'anticorps contre des séquences humaines. L'invention porte également sur une lignée cellulaire d'hybridomes générant des anticorps contre des séquences humaines et adaptée au développement de milieux exempts de sérum ou de milieux exempts de composants dérivés d'animaux. Une lignée cellulaire d'hybridomes générant des anticorps contre CTLA4 est idéalement préférée.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)